Transcriptomic Responses and Survival Mechanisms of Staphylococci to the Antimicrobial Skin Lipid Sphingosine.
Staphylococcus
drug resistance evolution
resistance
skin
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
15 02 2022
15 02 2022
Historique:
pubmed:
14
12
2021
medline:
23
3
2022
entrez:
13
12
2021
Statut:
ppublish
Résumé
Sphingosines are antimicrobial lipids that form part of the innate barrier to skin colonization by microbes. Sphingosine deficiencies can result in increased epithelial infections by bacteria including Staphylococcus aureus. Recent studies have focused on the potential use of sphingosine resistance or its potential mechanisms. We used RNA-Seq to identify the common d-sphingosine transcriptomic response of the transient skin colonizer S. aureus and the dominant skin coloniser S. epidermidis. A common d-sphingosine stimulon was identified that included downregulation of the SaeSR two-component system (TCS) regulon and upregulation of both the VraSR TCS and CtsR stress regulons. We show that the PstSCAB phosphate transporter, and VraSR offer intrinsic resistance to d-sphingosine. Further, we demonstrate increased sphingosine resistance in these staphylococci evolves readily through mutations in genes encoding the FarE-FarR efflux/regulator proteins. The ease of selecting mutants with resistance to sphingosine may impact upon staphylococcal colonization of skin where the lipid is present and have implications with topical therapeutic applications.
Identifiants
pubmed: 34902269
doi: 10.1128/AAC.00569-21
pmc: PMC8846397
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
Lipids
0
Sphingosine
NGZ37HRE42
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0056921Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L023040/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/D003563/1
Pays : United Kingdom
Références
J Bacteriol. 2001 Jan;183(2):468-75
pubmed: 11133939
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Infect Immun. 2008 Jan;76(1):141-52
pubmed: 17954724
Nat Protoc. 2006;1(3):1559-82
pubmed: 17406449
Biochemistry. 2008 Sep 2;47(35):9300-8
pubmed: 18690712
Genes (Basel). 2016 Oct 03;7(10):
pubmed: 27706107
J Invest Dermatol. 2002 Aug;119(2):433-9
pubmed: 12190867
PLoS One. 2013 Jul 04;8(7):e67698
pubmed: 23861785
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
PLoS One. 2015 Apr 08;10(4):e0123027
pubmed: 25853849
J Bacteriol. 2009 Dec;191(23):7306-14
pubmed: 19783632
J Mol Med (Berl). 2019 Aug;97(8):1195-1211
pubmed: 31222488
J Infect Dis. 2014 May 1;209(9):1485-93
pubmed: 24280365
Antimicrob Agents Chemother. 2012 Mar;56(3):1157-61
pubmed: 22155833
Sci Rep. 2017 Sep 6;7(1):10697
pubmed: 28878347
PLoS Pathog. 2011 Nov;7(11):e1002359
pubmed: 22102812
Mol Microbiol. 2003 Aug;49(3):807-21
pubmed: 12864861
Dermatoendocrinol. 2009 Mar;1(2):72-6
pubmed: 20224687
Future Microbiol. 2014;9(1):75-91
pubmed: 24328382
Microbiol Mol Biol Rev. 2005 Jun;69(2):326-56
pubmed: 15944459
J Invest Dermatol. 1992 Mar;98(3):269-73
pubmed: 1545135
J Bacteriol. 2008 May;190(10):3419-28
pubmed: 18344360
Front Microbiol. 2018 Nov 19;9:2753
pubmed: 30510546
mBio. 2013 Feb 12;4(1):e00537-12
pubmed: 23404398
Antimicrob Agents Chemother. 1994 Apr;38(4):857-60
pubmed: 8031059
BMC Syst Biol. 2011 May 12;5:68
pubmed: 21569391
Infect Immun. 2004 May;72(5):3073-6
pubmed: 15102825
Science. 1974 Oct 4;186(4158):19-26
pubmed: 4607408
Microbiol Mol Biol Rev. 2000 Dec;64(4):672-93
pubmed: 11104814
J Biol Chem. 2008 May 2;283(18):12354-64
pubmed: 18326495
EMBO Mol Med. 2014 Aug 01;6(9):1205-14
pubmed: 25085879
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
EMBO J. 2010 Nov 3;29(21):3621-9
pubmed: 20852588
Cell Physiol Biochem. 2016;38(6):2094-102
pubmed: 27184795
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Annu Rev Biochem. 1986;55:397-425
pubmed: 3527048
Front Microbiol. 2019 May 28;10:1157
pubmed: 31191485
J Mol Med (Berl). 2020 Feb;98(2):209-219
pubmed: 31863153
J Invest Dermatol. 2002 Nov;119(5):1090-5
pubmed: 12445197
Front Microbiol. 2020 May 26;11:865
pubmed: 32670206
J Bacteriol. 2015 Jun;197(11):1893-905
pubmed: 25802299
J Bacteriol. 2006 Jun;188(12):4183-9
pubmed: 16740924
J Biol Chem. 2020 May 29;295(22):7686-7696
pubmed: 32327486
Mol Microbiol. 2002 Jun;44(5):1269-86
pubmed: 12028379
J Infect Dis. 2005 May 15;191(10):1771-7
pubmed: 15838806
Front Microbiol. 2017 Jan 25;8:33
pubmed: 28179897
BMC Microbiol. 2011 Jun 24;11:146
pubmed: 21702925
J Bacteriol. 2012 Oct;194(19):5294-304
pubmed: 22843840
Infect Immun. 2005 Jun;73(6):3492-501
pubmed: 15908378
Mol Microbiol. 2017 Mar;103(5):860-874
pubmed: 27997732
BMC Genomics. 2011 Sep 07;12:444
pubmed: 21899761
Antimicrob Agents Chemother. 2007 Jun;51(6):2092-9
pubmed: 17420206
Mol Microbiol. 1999 Jan;31(1):117-31
pubmed: 9987115
J Exp Med. 2005 Jul 18;202(2):209-15
pubmed: 16009720
PLoS One. 2009;4(2):e4344
pubmed: 19183815
Antimicrob Agents Chemother. 2006 Jun;50(6):2137-45
pubmed: 16723576
Chem Biol. 2012 Apr 20;19(4):498-506
pubmed: 22520756